To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

• Status: Withdrawn
• Trial end date: 2011-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be applied to the affected skin, excluding the face, once daily, at approximately the same time daily.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fougera Pharmaceuticals Inc.

Criteria

Inclusion Criteria:

• Diagnosis of stable, symptomatic plaque psoriasis

• Good health with the exception of psoriasis

• % BSA and plaque elevation requirements

Exclusion Criteria:

• Subjects who are pregnant, nursing or planning a pregnancy within the study participation period.

• Subjects who have any systemic or dermatological disorders with the exception of psoriasis